Clinical Pharmacokinetics of N-Acetylcysteine

Clinical Pharmacokinetics

Volumn 20, Issue 2, 1991, Pages 123-134

  Holdiness, Mack R ^a  

^a TULANE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; CYCLOPHOSPHAMIDE; DOXORUBICIN; GLUTATHIONE; IFOSFAMIDE; PARACETAMOL;

CARDIOMYOPATHY; DIARRHEA; HEMORRHAGIC CYSTITIS; HUMAN; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY DISEASE; LIVER DISEASE; LUNG DISEASE; ORAL DRUG ADMINISTRATION; PHARMACOKINETICS; PREGNANCY; PRIORITY JOURNAL; REVIEW; VOMITING;

ACETYLCYSTEINE; ANIMAL; BIOLOGICAL AVAILABILITY; DRUG INTERACTIONS; FEMALE; HUMAN; PREGNANCY;

EID: 0025959339     PISSN: 03125963     EISSN: 11791926     Source Type: Journal    
DOI: 10.2165/00003088-199120020-00004     Document Type: Article

References (38)

1. A sensitive fluorometric determination of N-acetylcysteine in biological fluids by HPLC
2. Oral acetylcysteine reduces exacerbation rate in chronic bronchitis: report of a trial organized by the Swedish Society for Pulmonary Diseases
3. Toxicological, pharmacokinetic and metabolic studies on acetylcysteine
4. Pharmacokinetics of N-acetylcysteine in man
5. No penetration of orally administered N-acetyltysteine into bronchoalveolar lavage fluid
6. Methodologies for the analysis of reduced and oxidized’ N-acetylcysteine in biological systems
7. Pharmacokinetics and bioavailability of oral acetylcysteine in healthy volunteers
8. Measurement of penicillamine and N-acetylcysteine in human blood by HPLC and electrochemical detection
9. Determination of N-acetylcysteine in biological fluids
10. Determination of 3-mercaptolactate, mer-captoacetate and N-acetylcysteine in urine by gas chromatography
11. HPLC determination of N-acetylcysteine in human serum following acetaminophen overdosage
12. Determination of N-acetylcysteine, intact and oxidized, in plasma by column liquid chromatography and post column derivatization
13. Determination of non-protein bound N-acetylcysteine in plasma by HPLC
14. Adsorption of oral antidotes for acetaminophen poisoning (methionine and N-acetylcysteine) by activated charcoal
15. Comparison of electrochemical detection methods in liquid chromatography for determination of N-acetylcysteine in plasma
16. N-acetylcysteine pro-teas against the hepatotoxicity of acetaminophen by reducing the reactive metabolites in rats in vivo
17. HPLC assay for N-acetylcysteine in plasma and urine
18. Improved method for the determination of N-acetylcysteine in human plasma by HPLC
19. Biological properties of a cetylcysleine: assay development and pharmacokinetic studies
20. Clinical safety of high oral doses of acetylcysteine
21. Lung protection by a thiol-containing antioxidant: N-acetylcysteine
22. Protective effect of N-acetylcysteine on the urotoxicity produced by oxa-zaphosphosine without interference with anticancer activity
23. N-acetylcysteine: its bioavailability and interaction with ifosfamide metabolites
24. Long term oral acetylcysteine in chronic bronchitis, a double blind controlled study
25. Studies on the metabolism of isophosphamide in man
26. Effects of activated charcoal administration on acetylcysteine serum levels in humans
27. Pharmacokinetics and bioavailability of reduced and oxidized N-acetylcysteine
28. Studies in the sulphur metabolism of the dog. The preparation and metabolism of d-acetylcysteine
29. The treatment of acetaminophen poisoning
30. Colorimetric determination of acetylcysteine, penicillamine, and mercaptopropionolgly-cine in pharmaceutical dosage forms
31. Pharmacokinetics of oral acetylcysteine: absorption, binding and metabolism in patients with respiratory disorders
32. Pharmacokinetics of oral acetylcysteine: absorption, binding and metabolism in patients with respiratory disorders
33. Metabolic studies wth acetylcysteine
34. HPLC and fluorometric detection of biologically important thiols, derivatized with ammonium 7-lluo-robenzo-2-oxa-1, 3-diazole-4-sulphonate
35. N-acetylcysteine prevents the doxorubicin induced decrease of cyclic GMP
36. Acetylcysteine: a drug with an interesting past and a fascinating future